← Eichor
Condition: Molecular Imaging Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Molecular Imaging

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder
NA · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06629207
CLIMB: CNS Lymphoma Imaging and Molecular Biomarkers Study
Phase N/A · 1 location(s) · Royal Marsden NHS Foundation Trust · NCT05828628
Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities
NA · 1 location(s) · Mayo Clinic · NCT06058650
Establishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for Breast Cancer Based on Molecular Im
NA · 1 location(s) · Peking University Cancer Hospital & Institute · NCT06715020
Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.
NA · 1 location(s) · Jules Bordet Institute · NCT07119294
Molecular and Imaging Studies of Cardiovascular Health and Disease
Phase N/A · 1 location(s) · National Heart Centre Singapore · NCT02804269
The Role of the Imaging FAPI PET/CT in Exploring the Microenvironment of Colorectal Cancer Liver Metastases
NA · 1 location(s) · Jules Bordet Institute · NCT07109440
Molecular Imaging of the Underlying Mechanism of Vessel Wall Inflammation Using Positron Emission Tomography (PET/CT)
Phase N/A · 1 location(s) · University of Pennsylvania · NCT07548099
Molecular Imaging of Inflammation in Parkinson's Disease Using LPS and TSPO-PET/MR
Phase N/A · 1 location(s) · University of Exeter · NCT05205291
Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors
NA · 1 location(s) · Jules Bordet Institute · NCT06107608
Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
Phase 1 · 1 location(s) · University of Alabama at Birmingham · NCT04362644
PD-L1 Targeting Molecular Imaging of Solid Tumors
NA · 1 location(s) · Peking University Cancer Hospital & Institute · NCT04629326
PRE-I-SPY Phase I/Ib Oncology Platform Program
Phase 1 · 7 location(s) · QuantumLeap Healthcare Collaborative · NCT05868226
Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed
Phase 1 · 1 location(s) · University Medical Center Groningen · NCT05725876
Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Phase 4 · 4 location(s) · Silesian Centre for Heart Diseases · NCT05465031
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resi
Phase 2 · 1 location(s) · National Institute of Mental Health (NIMH) · NCT06511908
Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT05528744
Molecular Imaging in Fabry Disease of the Heart
Phase N/A · 1 location(s) · University of Cambridge · NCT06226987
Fluorescence Imaging of IBD and RA Using Adalimumab-800CW
Phase 2 · 1 location(s) · University Medical Center Groningen · NCT03938701
Artificial Intelligence-based Platform, Integrating Pathologic, Imaging and Molecular Profiles of Prostate Cancer
Phase N/A · 1 location(s) · Azienda Ospedaliero Universitaria Maggiore della Carita · NCT06468332
Research Into Diagnostic and Prognostic Molecular and Imaging Biomarkers of Ocular Disorders Associated With Neurovascul
NA · 1 location(s) · Clinact · NCT06466018
Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Un
Phase 2 · 2 location(s) · Integro Theranostics · NCT07276789
The Use of Molecular Radiogenomics in Non-small Cell Lung Cancer
Phase N/A · 1 location(s) · Buddhist Tzu Chi General Hospital · NCT05541744
Neuroimaging and Biomarkers of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy
Phase N/A · 1 location(s) · University of California, San Diego · NCT07075523
Early Life Stress and Depression: Molecular and Functional Imaging
Phase N/A · 1 location(s) · Mclean Hospital · NCT04713722
MR Microstructural Imaging for Prostate Cancer Diagnosis
Phase N/A · 6 location(s) · First Affiliated Hospital of Zhejiang University · NCT07249281
Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients
Phase 1 · 1 location(s) · Massachusetts General Hospital · NCT03535545
Study on the Diagnostic Value of Novel PET Molecular Imaging for Renal Cell Carcinoma
NA · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT07301827
Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative Dementia
Phase N/A · 8 location(s) · Ruijin Hospital · NCT06534658
Fluorocholine PET/MR in Breast Cancer
Phase N/A · 1 location(s) · Taipei Veterans General Hospital, Taiwan · NCT07587086
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.